GENEWATCH
 
Volume 25 Issue 5
 
 
Volume 25 Issue 5
Genome Sequencing in Medicine
Oct-Nov 2012
 
Will Insurance Cover Genome Sequencing?
By CRG staff - interview with Joanne Armstrong
 
Doctors (Cautiously) Onboard
By Jeremy Lazarus
 
Privacy in the Age of Revelation
By CRG staff - interview with Anita Allen
 
In Memoriam: A Tribute to Barry Commoner
By Sheldon Krimsky
 
More Science Than Art
By Paul Billings
 
The Genome Sequencing and Privacy Report: A Missed Opportunity
By Mark A. Rothstein
 
Computer Science
By CRG staff - interview with Steven Salzberg
 
Managing Your Genetic Portfolio
By Maggie Curnutte, Melody Slashinski
 
Great Expectations, Modest Returns
By Donna Dickenson
 
Questioning the Utility of Whole Genome Sequencing
By Helen Wallace
 
The Complicated Cost-Benefit Calculus of Newborn Screening
By Vani Kilakkathi
 
Notes From the Field: Forensic Genetics in India
By Jeremy Gruber
 
Topic Update: GMO Labeling
By CRG Staff
 
Editor's Note
By Samuel W. Anderson
 
 
Search: GeneWatch
 
 
 
The use of forensic DNA databases by law enforcement around the globe is expanding at a rate that should be of great concern to civil libertarians.
 
View Project
 
 
Created in 1999 by the Council for Responsible Genetics, the Safe Seed Pledge helps to connect non-GM seed sellers,distributors and traders to the growing market of concerned gardeners and agricultural consumers. The Pledge allows businesses and individuals to declare that they "do not knowingly buy, sell or trade genetically engineered seeds," thus assuring consumers of their commitment.
 
View Project
 
 
Tools
PAGE TOOLS
 
 
 
 
ON THE WEB